Adaptive Biotechnologies
ADPT
ADPT
209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 221 → 209 (-12)
25% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 40
38% less capital invested
Capital invested by funds: $1.74B → $1.08B (-$657M)
Holders
209
Holding in Top 10
2
Calls
$1.62M
Puts
$417K
Top Buyers
| 1 | +$25.2M | |
| 2 | +$24.7M | |
| 3 | +$8.32M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.81M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$5.54M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$13.9M | |
| 3 | -$10.9M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$9M |
| 5 |
TM
Tiger Management
New York
|
-$8.18M |